Interventions in antipsychotics-treated patients with cardiometabolic risk factors or metabolic syndrome

被引：1
|
作者：
Larsen, J. [1 ]
Holdrup, M. [2 ]
Christensen, B. [3 ]
Sigalin, C. [4 ]
Nilsson, P. M. [5 ]
Kolb, S. [6 ]
机构：
[1] Odense Univ Hosp, Dept Psychiat, Odense C, Denmark
[2] 3MDS Pharma Serv, Copenhagen, Denmark
[3] Aalborg Psychiat Hosp, Dept Psychiat, Aalborg, Denmark
[4] Ryhov Cty Hosp, Dept Psychiat, Jonkoping, Sweden
[5] Malmo Univ Hosp, Dept Clin Sci, Malmo, Sweden
[6] Pfizer, Med Affairs, Walton Oaks, England
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2008年 / 18卷
关键词：
D O I：
10.1016/S0924-977X(08)70648-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S440 / S441
页数：2
相关论文
共 50 条
  • [1] Metabolic Syndrome and Cardiometabolic Risk Factors
    Papakonstantinou, Emilia
    Lambadiari, Vaia
    Dimitriadis, George
    Zampelas, Antonis
    CURRENT VASCULAR PHARMACOLOGY, 2013, 11 (06) : 858 - 879
  • [2] Metabolic syndrome in schizophrenic patients treated with antipsychotics
    Peuskens, J
    De Hert, M
    Van Eyck, D
    Wampers, M
    de Patoul, A
    Hanssens, L
    Scheen, A
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 568 - 568
  • [3] The metabolic syndrome in schizophrenic patients treated with antipsychotics
    Van Eyck, D
    De Hert, M
    Hermans, G
    Peuskens, H
    Wampers, M
    de Patoul, A
    Hanssens, L
    Scheen, A
    Peuskens, J
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S255 - S255
  • [4] Evaluating Metabolic Syndrome Risk Factors in Patients Receiving Atypical Antipsychotics
    Gradek, Jaroslaw
    JOURNAL OF THE AMERICAN PSYCHIATRIC NURSES ASSOCIATION, 2013, 19 (01) : 34 - 35
  • [5] Metabolic syndrome and related factors treated with antipsychotics monotherapy and polypharmacy in patients with schizophrenia
    Oncu, Fatih
    Acuner, Tufan T.
    Atlar, Fatmahan
    Turkcan, Solmaz
    Yesilbursa, Dogan
    Uygur, Niyazi
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2009, 19 : S292 - S295
  • [6] Cardiovascular risk factors and metabolic syndrome in patients treated with long-acting injectables antipsychotics: a retrospective study
    De Carlo, Vera
    Grancini, Benedetta
    Cassina, Niccolo
    Casati, Lorenzo
    Piccoli, Eleonora
    Vismara, Matteo
    Gobbo, Dario
    Zanaschi, Raffaella
    Lupo, Susanna
    Olivieri, Silvia
    Dell'Osso, Bernardo
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2023, 38 (03) : 160 - 168
  • [7] Prevalence of metabolic syndrome in psychotic patients treated with antipsychotics
    Ferreiro Fernandez, B.
    Garcia Mahia, M. C.
    Vidal Millares, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S513 - S513
  • [8] Risk Factors of Metabolic Syndrome Among Patients Receiving Antipsychotics: A Retrospective Study
    Samer Hammoudeh
    Hawra Al Lawati
    Suhaila Ghuloum
    Huma Iram
    Arij Yehya
    Imen Becetti
    Nora Al-fakhri
    Hany Ghabrash
    Mena Shehata
    Nighat Ajmal
    Iman Amro
    Hira Safdar
    Yassin Eltorki
    Hassen Al-Amin
    Community Mental Health Journal, 2020, 56 : 760 - 770
  • [9] Risk Factors of Metabolic Syndrome Among Patients Receiving Antipsychotics: A Retrospective Study
    Hammoudeh, Samer
    Al Lawati, Hawra
    Ghuloum, Suhaila
    Iram, Huma
    Yehya, Arij
    Becetti, Imen
    Al-fakhri, Nora
    Ghabrash, Hany
    Shehata, Mena
    Ajmal, Nighat
    Amro, Iman
    Safdar, Hira
    Eltorki, Yassin
    Al-Amin, Hassen
    COMMUNITY MENTAL HEALTH JOURNAL, 2020, 56 (04) : 760 - 770
  • [10] THE RELEVANCE OF CARDIOMETABOLIC RISK FACTORS AS PREDICTORS OF THE METABOLIC SYNDROME
    Lindqvist, P.
    Sundh, V.
    Bjorkelund, C.
    Bengtsson, C.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
12345